D. Woodcock

Reversal of multidrug resistance by surfactants.

W. Sawyer, D. Woodcock, M. Linsenmeyer, 1992, British journal of cancer.

Biology of cell killing by 1-beta-D-arabinofuranosylcytosine and its relevance to molecular mechanisms of cytotoxicity.

D. Woodcock, P. Crowther, I. Cooper, 1985, Cancer research.

Response to cardiac sympathetic activation in transgenic mice overexpressing beta 2-adrenergic receptor.

A. Dart, E. Woodcock, C. Milano, 1996, The American journal of physiology.

Rapidly labelled ribonucleoprotein particles in rat liver cytoplasm and their relevance to the transport of messenger RNA.

J. Mansbridge, D. Woodcock, 1971, Biochimica et biophysica acta.

Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs.

B. Williams, D. Woodcock, M. Linsenmeyer, 1990, Cancer research.

Haematopoietic radioprotection by Cremophor EL: a polyethoxylated castor oil.

B. Williams, D. Woodcock, A. Kriegler, 1995, International journal of radiation biology.

Phase I trial of cremophor EL with bolus doxorubicin.

D M Woodcock, M. Millward, D. Rischin, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma.

J. Matthews, D. Woodcock, M. Linsenmeyer, 1992, British Journal of Cancer.

A low-affinity, low-molecular-mass endothelin-A receptor in neonatal rat heart.

E. Woodcock, D. Woodcock, M. Linsenmeyer, 1994, The Biochemical journal.

Assessing risk factors for transmission of infection.

I M Longini, J A Jacquez, J S Koopman, 1991, American journal of epidemiology.

Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype.

M. Millward, D. Woodcock, L. Webster, 1993, Journal of the National Cancer Institute.